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Protein translocation across the endoplasmic rettculum (ER) membrane of yeast can be inhibited by agents believed to specifically affect the 
transport of ATP through the membrane (Mayinger, P. and Meyer. D I. (1993) EMBO J. 12.659-666). suggesting the involvement of a translocatton 
component m the lumen of the ER that binds ATP. We demonstrate that one of the inhtbttors, 4,4’-diisothtocyanatostilbene-3.2’-disulfomc actd 
(DIDS), also affects the translocation of proteins mto mammahan microsomes. Translocation is blocked at the point of transfer of the nascent 
cham from the signal recogmtion particle (SRP) mto the ER-membrane. We also confirm that photoaffinity-labelhng of microsomes with 
8-aztdo-ATP inhibits the same early step of protem translocatton Since this step is reported to not require ATP. these results ratse the possibility 
that, m both cases. factor(s) other than ATP-bindmg components of the translocatton machmery are perturbed. 
Protein translocation: Endoplasmic rettculum; Photoaffimty labelling: Amon transporter 
I. INTRODUCTION of SRP so that it is available for subsequent rounds of 
translocation [5]. 
The driving force for the transport of proteins across On the other hand. evidence for an ATP-binding 
the endoplasmic reticulum (ER) membrane is as yet translocation component has been provided by pho- 
unknown. One possibility is that an ATP-hydrolyzing toaffinity labelling of mammalian microsomes with 8- 
component is located in the membrane or in the lumen azido-ATP [6,7]. The target component is neither cyto- 
of the ER membrane in order to push or pull the pol- plasmic nor identical to the lumenal BiP [S]. Both the 
ypeptide chain across the membrane. Alternatively. posttranslational transport of a small secretory protein 
ATP-dependent translocation component may not be and the cotranslational transport of preprolactin were 
needed. In the case of cotranslational translocation. the inhibited by S-azido-ATP. In the latter case, crosslink- 
protein-conducting channel in the membrane-bound ri- ing of the nascent chain to the TRAM protein [3] was 
bosome may simply be extended by a putative channel inhibited [8] (then presumed to be the a-subunit of the 
formed by proteins in the ER membrane: direction of signal sequence receptor (SSRcl). new name: ‘translo- 
transport would be determined by the exit from the con-associated protein’ (TRAP) [9]). These data indi- 
channel. In the case of posttranslational translocation, cated that an early step in translocation is inhibited by 
the folding of the polypeptide, its modification or its azido-ATP but, they failed to clarify whether, under 
binding to other proteins in the lumen of the ER may these conditions, the nascent chain was indeed targeted 
bias its diffusion across the membrane [l]. to the membrane. 
For the mammalian system it has been reported that 
translocation, per se, does not require ATP [2]. GTP 
binding, but not hydrolysis, is required for the transfer 
of the nascent chain from its initial interaction partner 
in the cytosol, the 54 kDa polypeptide of the SRP 
(SRP54), into the ER membrane, where it interacts with 
both the TRAM-protein and Secblp [3,4]. A short nas- 
cent chain can be completely transferred across the 
membrane after its release from the ribosome by puro- 
mycin, without the need for nucleotide triphosphate hy- 
drolysis [2]. GTP-hydrolysis is required for the recycling 
In yeast. the initial membrane insertion of a ribo- 
some-bound nascent chain of prepro-a-factor is also 
ATP-independent [lo]. However, the posttranslational 
translocation of a larger domain of this protein does not 
require ATP [ll-131. The ATP does not seem to be 
needed exclusively for the function of a cytosolic 
chaperone, since it is required even after denaturation 
of the polypeptide by urea [14]; a membrane-bound or 
lumenal ATP-binding component may therefore be in- 
volved. This component may be BiP (Kar2), a lumenal 
ATP-binding chaperone, mutations in which can affect 
the translocation process [ 151. 
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Recently, additional evidence for a lumenal ATP- 
binding translocation component was provided by ex- 
periments in which the transport of prepro-a-factor into 
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Fig. 1. Inhibition of the translocation of prepro-a-factor by DIDS. The translocation of wild type prepro-a-factor was tested by adding dog 
pancreatic microsomes, pretreated with different concentrations of DIDS, to an in vitro translation system. Controls were performed with untreated 
(lanes 2,ll) and mock-treated (lanes 3,121 microsomes. After translocation. half of the sample was treated with protease (lanes lo- 18). The products 
were analyzed by SDS-gel electrophoresis. followed by fluorography. ppaF, prepro-d-factor: paF, pro-c&factor espectively; the numbers on the 
lefthand side of the gel indicate the positions of the glycosylated forms. carrying 1. 2 or 3 carbohydrate chains. 
yeast microsomes could be inhibited by reagents that 
inhibit ATP-translocation through the ER membrane, 
namely, DIDS and benzoyl-ATP [l&17]. It was there- 
fore surmised that these reagents caused a decrease of 
the lumenal ATP-concentration which, in turn, inhib- 
ited an ATP-binding translocation component. These 
results raised the possibility that inhibitors of the ATP- 
translocator may be used to clarify the conflicting situ- 
ation in the ma~ali~n system. 
In this paper, we report that DIDS also inhibits pro- 
tein translocation into mammalian microsomes. How- 
ever. it is an early step that is inhibited. i.e. the transfer 
of the nascent chain from the SRP into the ER mem- 
brane, during which lumenal components are unlikely 
to play a role and which is reported to be ATP-inde- 
pendent [2]. The inhibition by azido-ATP appears to 
occur at the same step. Our results therefore raise the 
possibility that both treatments affect factors other than 
ATP-binding components of the translocation machin- 
ery. 
2. MATERIALS AND METHODS 
2.1. In vitro transcription 
Transcripts coding for the pPL86mer and for full-length pre- 
prolactin were produced with T7 polymerase using the template, plas- 
mid pGEMBP1 [9], linearized with PvuII and PstI, respectively. 
mRNAs for the wild type prepro-a-factor and the deletion mutant 
424-89 were synthesized by transcription with SP6 polymerase of the 
corresponding plasmids (pSP65-aF and pSP65-aF 424-89) [18] lmear- 
ized with San. For synthesis of a truncated version of the deletion 
mutant 424-89 that also lacks the C-terminal 5 amino acids, the plas- 
mrd was linearized with Neil. 
Translation in a rabbit reticulocyte iysate system (Promega) was 
carried out for 20 min at 30°C in a 10 ,~l volume. Where indicated, 
dog pancreatic microsomes, stripped of ribosomes by puromycinihigh 
salt treatment (PK-RM) [4], were present during translation at a final 
concentration of 0.1 eq/$l. After translation. half of the sample was 
incubated on ice for 30 min with 0.5 mglml proteinase K. The reaction 
was stopped by addition of 5 mM phenylmethylsulfonyl fluoride 
(PMSF). The proteins were precipnated with ammonium sulfate, 
washed with trichloroacetic acid and acetone and subjected to SDS-gel 
electrophoresrs (12.5% acrylamide). 
Photocrosslinking with the pPL86mer and the truncated version of 
the deletion mutant 424-89 of prepro-a-factor was performed essen- 
tially as described [19.20]. Brietly. the ribosomelnascent chain/SRP- 
complexes were formed by translation for 2 min at 26°C in a wheat 
germ system m the presence of modified lysyl-tRNA, carrying a pho- 
toreactive group in the side chain of the amino acid. Further lnltiation 
was stopped with 4pM edeme, and S ~1 translation mixture were then 
Incubated with 1 eq. membranes for 10 min on ice, followed by 4 min 
at 26°C. The samples were irradtated for 5 min and then submitted 
to SDS-gel electrophoresis (lo-20% acrylamide). 
2.4. Flotution of nrenrbranes after crasslinking 
To separate membrane-bound from cytosolic crosslinked products, 
the samples were adjusted to 2 M sucrose, 5 mM magnesium acetate, 
500 mM potassium acetate and layered under a 100 &I cushion con- 
taining 1.8 M sucrose, 50 mM HEPES/KOH. pH 7.5, 5 mM magne- 
sium acetate, 500 mM potassium acetate, 1 mM dithiothrettol. 50 ,uI 
of 250 mM sucrose in the same buffer was layered on top of the 
samples in a Beckman polycarbonate tube. The membranes were 
floated by cent~fugation m a Beckman TLlOO rotor for 1 h at 100,000 
rpm at 4°C. 
2.5. Treatment qf PK-RM with arido-ATP and DIDS 
Microsomes were incubated with 8-azido-ATP as described by 
Klappa et al. [6]. The samples were irradiated for 5 mm on ice. Treat- 
ment of microsomes with DIDS was performed as described by May- 
inger et al. [16]. 
3. RESULTS AND DISCUSSION 
We first tested whether DIDS inhibited translocation 
of the secretory protein prepro-&factor into canine 
pancreatic microsomes in the same manner as it inhib- 
ited translocation of the same protein into yeast micro- 
somes 1161 (Fig. 1). Prepro-a-factor was synthesized in 
the reticulocyte lysate system in the presence of dog 
pancreatic microsomes that had been pretreated with 
increasing concentrations of DIDS. Translocation, de- 
termined by the appearance of ~-glycosylated polypep- 
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Fig. 2. Inhibitton of the translocatton of preprolactm and of a deletion 
mutant of prepro-a-factor 424-89 by DIDS. Translocated material 
was analyzed following proteolysts. The experiments were performed 
as described in Fig. 1 
tides of lower mobility in SDS-gels (Fig. 1. lane 2 vs. 1) 
and by the occurrence of protease-protected material 
(lanes 10-18) was clearly inhibited by DIDS. Half-max- 
imum inhibition occurred at about 0.5 mM. in good 
agreement with the results obtained for yeast micro- 
somes [16]. This suggests that DIDS likely affects a 
similar step in both systems. In our case, DIDS must 
have inhibited the cotranslational translocation of pre- 
pro-a-factor (translocation of prepro-a-factor in the 
mammalian system does not occur with nascent chains 
released from the ribosome [21]), whereas in yeast it 
might have only influenced the posttranslational mode 
of translocation, even if the microsomes were added 
during translation [ 161. 
DIDS also inhibits the translocation into mammalian 
microsomes of preprolactin and of a short fragment of 
prepro-a-factor that carries a deletion in its pro-region 
(Fig. 2) [18]. In both cases, half-maximum inhibition 
again occurred at about 0.5 mM. 
We then determined at which step translocation is 
inhibited by DIDS. To this end, a fragment of the dele- 
tion mutant of prepro-a-factor was synthesized. con- 
taining photoreactive lysine derivatives instead of un- 
modified lysines in the polypeptide chain. This was then 
photocrosslinked in the absence or presence of micro- 
somes (Fig. 3A) [22.23]. In the absence of membranes, 
crosslinks to SRP54 were observed (lane 1), whereas in 
the presence of untreated microsomes, most crosslinks 
were to the membrane protein Sec6lp (lane 2), as iden- 
tified by immunoprecipitation with specific antibodies 
(data not shown). Pretreatment of the microsomes with 
increasing concentrations of DIDS caused the gradual 
disappearance of the Sec6lp-crosslinks and a concomi- 
tant increase of SRP54-crosslinks (lanes 3-S). These 
changes occurred within the range of DIDS-concentra- 
tions that caused inhibition of translocation (Figs. 1 and 
2B). Our data indicate that DIDS affects translocation 
by inhibiting the transfer of nascent chains from the 
SRP into the ER membrane. 
These results were confirmed by the use of a protease- 
protection assay for the membrane insertion of nascent 
270 
chains (Fig. 3B) [2]. In the absence of membranes (lane 
1) or in the presence of membranes pretreated with high 
concentrations of DIDS (lanes 668), only a low molecu- 
lar weight peptide was protected from the protease at- 
tack. The fragment is believed to be the nascent chain 
within the ribosome 121. In the presence of active micro- 
somes, the complete fragment was protected (lanes 2-5). 
indicating that in this case. membrane proteins shield 
the nascent chain as well. Again. inhibition of mem- 
brane insertion of the nascent chain occurred at approx- 
imately the same concentration of DIDS at which inhi- 
bition of translocation had been observed. 
To confirm these results, a second protein was inves- 
tigated. An 86 amino acid fragment of preprolactin 
(pPLS6mer). containing the photoreactive probes exclu- 
sively in its signal sequence, was employed in the 
crosslinking assay (Fig. 4). In the absence of micro- 
somes, the signal sequence is crosslinked to SRP54 (lane 
PK-RM - + + + + + + + 
DIDS tmM) - - .WI .OI .I .j 1 2 
aFtA24-89 x SRP54 - 
aFtA24-89 x Set 61 - l 
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aFt A24-89 - 
Fig 3. Inhibition by DIDS of the membrane insertion of a short 
prepro-a-factor chain. (A) A truncated version of the drletton mutant 
of prepro-a-factor 424-89 (aF 424-89) was synthesized m vitro m the 
presence of incorporated photoreactive lysme dertvatives. Crosshnk- 
mg was analysed with both mtcrosomes pretreated wtth different con- 
centrations of DIDS (lanes 3-S) and wtth untreated microsomes (lane 
2). A second control was carrted out m the absence of microsomes 
(lane Il. Crosslmks to the 54 kDa polypeptide of SRP (SRP54) and 
to Sec6lp (dots) are as indicated. (B) The insertton of the truncated 
nascent chain aF424-89 mto microsomes was confirmed by treatment 
with protease. The arrow indicates the position of the fragment of the 
nascent chain that is presumably exclusively protected by the ribo- 
some. 
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Fig. 4. Inhibition by DIDS of the membrane msertion of a short 
fragment of preprolactin. A fragment of preprolactin containing 86 
amino acids (pPL86mer) was synthesized in vitro in the presence of 
photoreactive lysine derivatives. The experiment was performed as in 
Fig. 3A. The crosslinks to the TRAM protein are as Indicated 
1) [24,25], whereas in the presence of untreated micro- 
somes crosslinking occurs predominantly to the 
l’li-Rll -+++++ 
azido-.\TP (mhl) 0 2 4 8 16 
pPL8bmer s SRP54 - 
pPL86mer s TRAhl - 
TRAM-protein (86mer x TRAM; lane 2) [3]. Pretreat- 
ment of microsomes with increasing concentrations of 
DIDS resulted in a parallel increase in the intensity of 
the SRP54-crosslinks (lanes 49). Crosslinking to the 
membrane proteins also changed dramatically; those to 
the TRAM protein disappeared at low DIDS concen- 
trations (verified by binding of the products to concana- 
valin A: data not shown) and other (non-glycosylated) 
crosslinks were seen in an intermediate range of DIDS 
concentrations. Half-maximum effects of DIDS on the 
insertion of the nascent chain were seen at about the 
same concentration needed for half-maximum inhibi- 
tion of translocation of full-length preprolactin (cf. Fig. 
2A). The inhibition of membrane insertion of the 86mer 
of preprolactin could also be confirmed by the protease- 
protection assay (data not shown). 
Similar observations were made with microsomes 
pretreated by irradiation in the presence of %azido- 
ATP. These membranes were not competent for protein 
translocation (half-maximum inhibition at about 24 
mM for preprolactin and for prepro-a-factor; data not 
shown), as reported by others [7,8]. It should be noted, 
however, that in the case of the prepro-a-factor deletion 
mutant, the inhibition was not complete (data not 
shown). Crosslinking of the 86mer of preprolactin was 
again used to monitor the membrane insertion of the 
nascent chain (Fig. 5C). TRAM-crosslinks disappeared 
with microsomes photolyzed in the presence of 8-azido- 
ATP (lanes 336), whereas the SRP54 crosslinks reap- 
- +++++ -+++++ 
0 2 4 8 16 0 2 4 x 16 
I 2 3 4 5 6 7 8 9 10 11 12 13 1-t 15 10 17 IS 
n1en1hrme crosslinks cj tosolic crohslinhs total croz\liilhz 
Fig. 5. Inhibition of the membrane insertion of a short fragment of preprolactin by azido-ATP. A fragment of 86 amino acids of preprolactin 
(pPL86mer) was synthesized in the presence of photoreactive lysine derivatives Microsomes were pretreated by irradiation in the presence of 
different concentrattons of 8-azido-ATP. Photocrosshnked products of the nascent chain were either analyzed directly by SDS-gel electrophoresis 
and fluorography (total crosslinks) or first separated by fotatton into membrane-bound (membrane crosslinks) and cytosohc (cytosolic crosslinks) 
fractions. The crosslinks to SRP54 and to the TRAM-protein are as Indicated. 
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peared. Most of the SRP54-crosslinks were found in the 
cytosolic compartment after flotation of the membranes 
(Fig. 5B), whereas the TRAM-crosslinks were found 
associated with the membranes (Fig. 5A). These data 
show that inactivation of microsomes by photolabelling 
with 8-azido-ATP results in inhibition of the transfer of 
the nascent chain from the cytosolic SRP into the ER 
membrane. 
In conclusion, both treatment with DIDS and photo- 
labelling with 8-azido-ATP inhibit a translocation step 
that has been reported to not require ATP [2]. Also. 
components of the lumen of the ER are not likely to 
play a role during this early translocation phase when 
only a few, if any, amino acids of the translocated pol- 
ypeptide have reached the lumenal space. 
The simplest interpretation of our results is that 
DIDS and azido-ATP affect in addition to anion trans- 
porters and ATP-binding proteins, respectively, the 
SRP-receptor, the TRAM protein or Sec6lp. Both 
treatments result in covalent modifications of proteins 
and. in the case of photolabelling with azido-ATP. the 
reactive nitrene labels many proteins, including the CI- 
subunit of TRAP [7], which does not contain an ATP- 
binding domain. On the other hand. the nucleotide 
binding site of the a-subunit of the SRP-receptor does 
have a low affinity for ATP [2]. However, the inhibition 
of targeting has been observed even in the presence of 
a large excess of GTP [7], suggesting that modification 
of this site is not responsible. 
An alternative interpretation is that an ATP-requir- 
ing component functioning at a later stage of the proc- 
ess is indeed inhibited exclusively, but that the translo- 
cation intermediates accumulate. Although we cannot 
rule out this possibility, we consider it unlikely since one 
would have expected to detect membrane-inserted inter- 
mediates and thus crosslinks to Sec6lp and TRAM- 
protein (in addition to SRP54-crosslinks), which are the 
first membrane proteins encountered by the translo- 
eating nascent chains. Contrary to this expectation, 
there was always a reciprocal relationship between the 
crosslinks to SRP54 and the membrane proteins. 
In conclusion, our results indicate that, contrary to 
previous interpretations, the effects of DIDS and azido- 
ATP cannot be considered as firm evidence for the exis- 
tence of ATP-binding translocation components. 
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